---
title: "Ningbo Tianyi Medical Appliance Co., Ltd. (301097.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301097.SZ.md"
symbol: "301097.SZ"
name: "Ningbo Tianyi Medical Appliance Co., Ltd."
industry: "Health Care Supplies"
datetime: "2026-05-20T08:10:32.051Z"
locales:
  - [en](https://longbridge.com/en/quote/301097.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301097.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301097.SZ.md)
---

# Ningbo Tianyi Medical Appliance Co., Ltd. (301097.SZ)

## Company Overview

Ningbo Tianyi Medical Appliance Co., Ltd. engages in the research and development, production, and sale of medical polymer consumables and other medical devices to blood purification and ward nursing fields in China and internationally. It offers hemodialysis tubing, artis piping kits, displacement and replacement fluid tubing, puncture device, dialyzer, hemodialysis concentrate and dry powder, and citric acid disinfectant; CRRT piping and series, plasma perfusion devices and separators, blood filters, waste liquid bags, side port connection tube and pipes, and dialysis replacement fluid bag puncture devices; feeders, feeding extension tubes and nutrient bags, and extended straws; and disposable oxygen tubing, cannula, blood transfusion and rectal air sets, endoscopic flushing tube, sterile syringe and needles, and micro adjustable infusion sets. The company was incorporated in 1998 and is headquartered in Ningbo, China.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | CN Market |
| Website | [www.tianyi-med.com](https://www.tianyi-med.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: C (0.52)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 26 / 40 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 52.44% |  |
| Net Profit YoY | -826.12% |  |
| P/B Ratio | 3.15 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3519512193.31 |  |
| Revenue | 642250708.54 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -1.02% | D |
| Profit Margin | -1.84% | D |
| Gross Margin | 47.93% | B |
| Revenue YoY | 52.44% | A |
| Net Profit YoY | -826.12% | E |
| Total Assets YoY | 17.64% | A |
| Net Assets YoY | -6.64% | D |
| Cash Flow Margin | -772.97% | E |
| OCF YoY | 52.44% | A |
| Turnover | 0.32 | D |
| Gearing Ratio | 48.65% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Ningbo Tianyi Medical Appliance Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "52.44%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-826.12%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.15",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "3519512193.31",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "642250708.54",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-1.02%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-1.84%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "47.93%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "52.44%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-826.12%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "17.64%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "-6.64%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-772.97%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "52.44%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.32",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "48.65%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -297.69 | 39/40 | 266.47 | 253.78 | 243.04 |
| PB | 3.15 | 29/40 | 2.90 | 2.60 | 2.18 |
| PS (TTM) | 5.48 | 18/40 | 6.77 | 6.29 | 5.61 |
| Dividend Yield | 0.00% | - | 1.13% | 0.94% | 0.84% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Snibe (300832.SZ) | A | D | C | A | C | B |
| 02 | Winner Medical (300888.SZ) | B | B | B | B | B | B |
| 03 | Fuerjia (301371.SZ) | B | C | D | A | B | B |
| 04 | MTM (688029.SH) | B | B | B | A | B | B |
| 05 | Endovastec (688016.SH) | A | B | D | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2025-01-03T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 61.28 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/301097.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/301097.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/301097.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/301097.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**